Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRNT1 pseudogene 2 (TRNT1P2) is a pseudogene related to the functional TRNT1 (tRNA nucleotidyl transferase 1) gene. Pseudogenes are non-coding DNA sequences derived from once-functional genes but have lost their protein-coding potential due to mutations or lack of regulatory elements. Unlike the true TRNT1 gene, which encodes an essential enzyme for tRNA maturation and whose deficiency is linked to various diseases, TRNT1P2 does not code for a protein and has no known biological or therapeutic role. There are no drugs, disease associations, or clinical biomarkers related to TRNT1P2, and it is not considered a valid drug target[1][2][3][4][5].\n\nKey notes:\n- There is currently no evidence that TRNT1P2 is functional or relevant as a molecular target.\n- If you are interested in the active protein-coding TRNT1 gene, refer instead to "tRNA nucleotidyl transferase 1" (TRNT1); see sources for functions, disease implications, and possible therapeutic roles related to the functional gene[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRNT1 pseudogene 2 (TRNT1P2).